Self-Host
Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Mind Medicine (MNMD) Insider Trading Activity
Healthcare • Biotechnology • 57 employees
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.
Total Value
-$170,916.67
Total Shares
-9,019
Average Trade Value
-$17,091.67
Most Active Insider
Halperin Wernli Miri
Total Activity: $386,111
Largest Single Transaction
$201,111
by Halperin Wernli Miri on Aug 21, 2024
30-Day Activity
1 Transaction
Volume: 2,500 shares
Value: $17,925
|
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
|---|---|---|---|---|---|---|
| Dec 5, 2024 | 2,500 | $17,925 | 19,851 (+12.6%) | Purchase | ||
|
Chief Executive Officer
|
Sep 25, 2024 | 19,771 | $118,231 | 545,772 (-3.6%) | Sale | |
|
Chief Legal Officer
|
Sep 25, 2024 | 4,430 | $26,491 | 177,716 (-2.5%) | Sale | |
|
Chief Accounting Officer
|
Sep 25, 2024 | 2,352 | $14,065 | 99,543 (-2.4%) | Sale | |
|
Chief Medical Officer
|
Sep 25, 2024 | 6,871 | $41,089 | 344,656 (-2.0%) | Sale | |
| Aug 23, 2024 | 3,500 | $20,930 | 17,351 (+20.2%) | Purchase | ||
|
Executive President
|
Aug 21, 2024 | 50,000 | $185,000 | 235,000 (+21.3%) | Exercise/Conversion | |
|
Executive President
|
Aug 21, 2024 | 32,595 | $201,111 | 202,405 (-16.1%) | Payment of Exercise Price | |
|
Chief Executive Officer
|
Aug 20, 2024 | 500 | $3,060 | 565,543 (+0.1%) | Purchase | |
|
Chief Executive Officer
|
Aug 19, 2024 | 500 | $3,155 | 565,043 (+0.1%) | Purchase |